Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crystallization from solution versus mechanochemistry to obtain double-drug multicomponent crystals of ethacridine with salicylic/acetylsalicylic acids. | Sci Rep | 2024 | 38246926 | PubTator, text mining | PubMed |
| Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. | Nat Commun | 2024 | 38245530 | PubTator, text mining | PubMed |
| The knockdown of stathmin with si-RNA inhibits invasion of mesothelioma. | Tissue Cell | 2024 | 38244401 | PubTator, text mining | PubMed |
| Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma. | EBioMedicine | 2024 | 38244291 | PubTator, text mining | PubMed |
| Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma. | Sci Rep | 2024 | 38243040 | PubTator, text mining | PubMed |
| CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease. | NPJ Parkinsons Dis | 2024 | 38242875 | PubTator, text mining | PubMed |
| Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer. | Braz J Otorhinolaryngol | 2024 | 38228050 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. | J Transl Med | 2024 | 38216927 | PubTator, text mining | PubMed |
| Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets. | PLoS One | 2024 | 38215156 | PubTator, text mining | PubMed |
| The Ovary-Brain Connection. | Cells | 2024 | 38201298 | PubTator, text mining | PubMed |
| Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. | Nat Commun | 2024 | 38191557 | PubTator, text mining | PubMed |
| Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis. | Tumori | 2024 | 38183180 | PubTator, text mining | PubMed |
| Integrated analysis of miRNA-mRNA expression of newly emerging swine H3N2 influenza virus cross-species infection with tree shrews. | Virol J | 2024 | 38178220 | PubTator, text mining | PubMed |
| Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38169461 | PubTator, text mining | PubMed |
| MAD2L2, a key regulator in ovarian cancer and promoting tumor progression. | Sci Rep | 2024 | 38167649 | PubTator, text mining | PubMed |
| EFNB1 levels determine distinct drug response patterns guiding precision therapy for B-cell neoplasms. | iScience | 2024 | 38155773 | PubTator, text mining | PubMed |
| Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. | Cancer Med | 2024 | 38132831 | PubTator, text mining | PubMed |
| Changes in searching behaviour of CSL transcription complexes in Notch active conditions. | Life Sci Alliance | 2024 | 38097371 | PubTator, text mining | PubMed |
| Spatially Self-Organized Three-Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development. | Adv Sci (Weinh) | 2024 | 38037510 | PubTator, text mining | PubMed |
| The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review. | Cancer Rep (Hoboken) | 2024 | 38018319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=11